Pharmacologic considerations with antimicrobials used in oncology.
Postelnick
M
M
Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois 60611, USA.
Halbur
S R
SR
D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000517:prevention & control*; D002442:Ceftazidime / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D009369:Neoplasms / Q000276:immunology / Q000378:metabolism / Q000382:microbiology*; D009894:Opportunistic Infections / Q000517:prevention & control*; D010878:Piperacillin / Q000493:pharmacokinetics / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002442:Ceftazidime; D010878:Piperacillin